Science Applications International Corp amends credit agreement, establishes new loan facilities

Science Applications International Corp (SAIC) has refinanced its debt, securing a new $1.1 billion senior secured term loan A and a $1 billion revolving credit facility, both maturing in 2030, alongside a recent $500 million senior notes offering. This debt restructuring occurs as the company reported a Q2 FY2026 EPS beat but a revenue shortfall and a tight current ratio of 0.83. The mixed financial performance and strategic challenges have led to a JPMorgan downgrade to Neutral, despite Stifel maintaining a Buy rating, indicating a complex outlook for the defense contractor.

Analysis

Science Applications International Corp (SAIC) has executed a significant debt refinancing, establishing a new $1.1 billion senior secured term loan and a $1 billion revolving credit facility, both with extended maturities to September 30, 2030. This restructuring provides greater financial runway and was used to repay previous obligations, although it adds to a total debt position of $2.445 billion. The move comes amid a complex operational backdrop; in Q2 FY2026, SAIC reported a substantial earnings beat with an EPS of $3.63 against a $2.24 forecast, but simultaneously missed revenue expectations, posting $1.77 billion versus an anticipated $1.87 billion. This top-line weakness, coupled with a tight liquidity position indicated by a current ratio of 0.83, prompted a downgrade from JPMorgan to Neutral, citing a weakening revenue outlook. In contrast, Stifel maintained a Buy rating, albeit with a slightly reduced price target of $128, reflecting the conflicting signals in the company's performance. The successful refinancing and a separate $500 million senior notes offering demonstrate proactive capital management, but they do not resolve the underlying concerns about a challenged growth trajectory and strategic execution.

Key Decisions for Investors

• Investors should prioritize monitoring SAIC's top-line performance, as the recent revenue miss and JPMorgan's downgrade underscore that the company's primary challenge is its growth outlook, which overshadows the strong Q2 EPS beat.
• While the successful debt refinancing to 2030 improves the company's maturity profile, the tight liquidity, evidenced by a current ratio of 0.83, warrants caution and a focus on free cash flow generation and balance sheet management in upcoming quarters.
• Given the conflicting analyst ratings and the dichotomy between strong profitability and weak revenue, a neutral stance may be prudent until management provides clearer evidence of a successful strategic pivot and a return to sustainable top-line growth.